| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.076 | 0.1 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |